Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for hyperacute intracerebral hemorrhage (multi-center RCT)
ChiCTR2100045022Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in intracerebral hemorrhage (ICH) (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Proportion of hematoma expansion within 24 ± 12 hours. Started Feb 2021; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR2100045022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045022.